
Business
More carbs, fattier meals? What's changing in hawker dishes as food costs rise
By Marcus Chen
Advertisement · Why this ad?
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.